DE69529249T2 - Puderpräparat zur Heilung verletzter Haut - Google Patents

Puderpräparat zur Heilung verletzter Haut

Info

Publication number
DE69529249T2
DE69529249T2 DE69529249T DE69529249T DE69529249T2 DE 69529249 T2 DE69529249 T2 DE 69529249T2 DE 69529249 T DE69529249 T DE 69529249T DE 69529249 T DE69529249 T DE 69529249T DE 69529249 T2 DE69529249 T2 DE 69529249T2
Authority
DE
Germany
Prior art keywords
powder preparation
salts
injured skin
healing
healing injured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69529249T
Other languages
English (en)
Other versions
DE69529249D1 (de
Inventor
Toshio Inagi
Saibi Suehiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Publication of DE69529249D1 publication Critical patent/DE69529249D1/de
Application granted granted Critical
Publication of DE69529249T2 publication Critical patent/DE69529249T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
DE69529249T 1994-06-27 1995-06-09 Puderpräparat zur Heilung verletzter Haut Expired - Fee Related DE69529249T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14439394A JP3583166B2 (ja) 1994-06-27 1994-06-27 損傷皮膚修復用粉末製剤

Publications (2)

Publication Number Publication Date
DE69529249D1 DE69529249D1 (de) 2003-02-06
DE69529249T2 true DE69529249T2 (de) 2003-08-07

Family

ID=15361113

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69529249T Expired - Fee Related DE69529249T2 (de) 1994-06-27 1995-06-09 Puderpräparat zur Heilung verletzter Haut

Country Status (12)

Country Link
US (1) US5618799A (de)
EP (1) EP0689841B1 (de)
JP (1) JP3583166B2 (de)
KR (1) KR100370313B1 (de)
CN (1) CN1059088C (de)
AT (1) ATE230270T1 (de)
CA (1) CA2150888A1 (de)
DE (1) DE69529249T2 (de)
DK (1) DK0689841T3 (de)
ES (1) ES2189811T3 (de)
SI (1) SI0689841T1 (de)
TW (1) TW336173B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU722246B2 (en) * 1995-06-07 2000-07-27 Johnson & Johnson Consumer Products, Inc. Stable complexes of crosslinked polyvinylpyrrolidone and iodine and method of making the same
US6562885B1 (en) 1998-03-19 2003-05-13 Battelle Memorial Institute Composition for deactivating chemically and biologically active agents and method of making the same
CN1306444A (zh) 1998-06-19 2001-08-01 奥西比奥公司 具有抗感染和避孕性能的医学装置
US6414223B1 (en) * 1998-08-03 2002-07-02 Cargill, Incorporated Plants, seeds and oils having an elevated total monounsaturated fatty acid content
CA2355241A1 (en) 1999-02-26 2000-08-31 Warner-Lambert Company Bioadhesive antibacterial wound healing composition
JP2001122790A (ja) * 1999-10-22 2001-05-08 Mikasa Seiyaku Co Ltd 安定な褥瘡・皮膚潰瘍および創傷治療用製剤
US8323693B2 (en) 2002-03-14 2012-12-04 Medrx Co., Ltd. External preparation for wounds
AU2003252694A1 (en) * 2002-07-26 2004-02-16 Mikasa Seiyaku Co., Ltd. External preparation
EP1561467A4 (de) * 2002-11-11 2008-06-25 Kowa Co Zusammensetzung zur wiederherstellung geschädigter haut
US20040101507A1 (en) * 2002-11-27 2004-05-27 Janco Predovan Skin cream
AU2003293818A1 (en) * 2002-12-19 2004-07-14 Gunther Beisel Method for producing agents which are to be administered orally and corresponding compositions using polymers and coatings thereof consisting of hydrophilic liquids
RU2245723C1 (ru) * 2003-07-24 2005-02-10 Вилесов Александр Дмитриевич Средство и способ лечения гнойно-воспалительных заболеваний мягких тканей
WO2005027940A1 (ja) * 2003-09-22 2005-03-31 Kowa Co., Ltd. 損傷皮膚修復用貼付剤
US7673841B2 (en) 2004-03-25 2010-03-09 Cooper Technologies Company Hangar bar for recessed luminaires with integral nail
JP4575705B2 (ja) * 2004-04-23 2010-11-04 興和株式会社 損傷皮膚修復用組成物
JP4575706B2 (ja) * 2004-04-23 2010-11-04 興和株式会社 損傷皮膚修復用組成物
US7334538B1 (en) * 2004-07-27 2008-02-26 Aquascience Research Group, Inc. Topical medicants for aquatic animals
CN1279917C (zh) * 2004-09-09 2006-10-18 吕益明 一种创伤药及其制备方法和使用方法
SI1878426T1 (sl) 2005-04-26 2010-09-30 Dainippon Sumitomo Pharma Co Granulatni pripravek ki vsebuje bigvanidno spojino
NZ542258A (en) * 2005-09-06 2010-05-28 Comvita New Zealand Ltd A medical composition comprising honey or sugar syrup and a viscosity increasing agent for use on wounds
WO2007049952A1 (en) * 2005-10-28 2007-05-03 Nature Products Holding B.V. Polymeric compound, method of preparing a polymeric compound, use of a polymeric compound
EP2095812A4 (de) 2006-10-25 2011-07-13 Dainippon Sumitomo Pharma Co Nicht zusammenbackende granulatförmige zubereitung
KR101665705B1 (ko) * 2006-12-07 2016-10-12 다이이찌 산쿄 가부시키가이샤 안정성이 개선된 필름 코팅 제제
EP2100609A4 (de) * 2006-12-07 2010-01-06 Daiichi Sankyo Co Ltd Mannitol- oder lactosehaltige feste medizinische zubereitung
KR101647842B1 (ko) * 2006-12-07 2016-08-11 다이이찌 산쿄 가부시키가이샤 저장 안정성이 개선된 의약 조성물
WO2008072535A1 (ja) 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 低置換度ヒドロキシプロピルセルロースを含有する医薬組成物
JP2012502730A (ja) * 2008-09-22 2012-02-02 トリオシン・ホールディング・インコーポレイテッド 新規のヨウ素化樹脂製造方法および製品
CN101654499B (zh) * 2009-09-02 2011-08-31 陈煜� 天然高分子或其水溶性衍生物的两亲性接枝共聚物与纳米碘复合物及其制备方法
CN102846776B (zh) * 2012-09-28 2015-02-11 刘艳 一种由桃树末制成的药剂
WO2016109344A1 (en) * 2014-12-30 2016-07-07 3M Innovative Properties Company Bactericidal composition
AU2016209550A1 (en) * 2015-01-20 2017-08-03 Veloce Biopharma Llc Novel iodophor composition and methods of use
WO2022245963A1 (en) * 2021-05-18 2022-11-24 Javad Parvizi Nasal antiseptic

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2353297A1 (fr) * 1976-01-26 1977-12-30 Tissier Gerard Nouveaux complexes neutres et insolubles de la polyvinylpolypyrrolidone et des halogenes, leurs procedes d'obtention et leurs applications
US4094967A (en) * 1976-10-22 1978-06-13 Allor Foundation Iodine-polyvinylpyrrolidone solid product and method of preparation
AU536885B2 (en) * 1979-04-18 1984-05-31 R. A. Knutson Wound and burn dressing
DE3312431A1 (de) * 1983-04-07 1984-10-11 B. Braun Melsungen Ag, 3508 Melsungen Pvp-iod-wundpuder mit synergistisch wirkender pudergrundlage
NL8500774A (nl) * 1985-03-18 1986-10-16 Dagra Nv Werkwijze ter bereiding van een vrij vloeiend, homogeen povidonjood wondpoeder.
CA1287584C (en) * 1986-09-02 1991-08-13 Seiichi Komori Wound-healing preparations
GB8622012D0 (en) * 1986-09-12 1986-10-22 Euro Celtique Sa Solid iodophor composition
CH678697A5 (de) * 1989-04-03 1991-10-31 Warner Lambert Co
US4877927A (en) * 1989-04-06 1989-10-31 Hamlin Incorporated Extended dwell shock sensing device

Also Published As

Publication number Publication date
CN1124143A (zh) 1996-06-12
EP0689841A1 (de) 1996-01-03
ATE230270T1 (de) 2003-01-15
TW336173B (en) 1998-07-11
KR960000214A (ko) 1996-01-25
US5618799A (en) 1997-04-08
CA2150888A1 (en) 1995-12-28
DE69529249D1 (de) 2003-02-06
SI0689841T1 (en) 2003-04-30
EP0689841B1 (de) 2003-01-02
JP3583166B2 (ja) 2004-10-27
ES2189811T3 (es) 2003-07-16
KR100370313B1 (ko) 2003-03-19
CN1059088C (zh) 2000-12-06
DK0689841T3 (da) 2003-02-24
JPH0812582A (ja) 1996-01-16

Similar Documents

Publication Publication Date Title
DE69529249D1 (de) Puderpräparat zur Heilung verletzter Haut
EP0366101A3 (de) Verfahren zum Ueberdecken des Geschmacks von Ibuprofon
CA2356310A1 (en) External preparations containing a basic drug
AU3990797A (en) Sustained release formulation
TW229217B (de)
EP0386960A3 (de) Pharmazeutische Zusammensetzungen zur Verwendung als Wirkstoffabgabevehikel und/oder als Wundverband
AU6949594A (en) Substituted oxazolyl compounds for the treatment of inflammation
CA2174072A1 (en) Hydrogel-forming, self-solvating absorbable polyester block copolymers, and methods for use thereof
CA2160182A1 (en) Antimicrobial adhesive composition for dental uses
EP0992501A3 (de) Pyridoncarbonsäurederivate als antibakterielle Wirkstoffe
UA27748C2 (uk) Похідні піримідину, що мають активність антагоністів ангіотензину іі, спосіб їх отримання та фармацевтична композиція
CA2395846A1 (en) Diazepan derivatives or salts thereof
WO2004060273A3 (en) Skin care composition containing an anionic polymer
DE69716586T2 (de) Gepufferte orthoesterpolymere enthaltende arzneimittel
FR2681777B1 (fr) Clou chirurgical implantable dans l'os.
WO1996005845A3 (en) Treatment of disease and conditions associated with macrophage infiltration in particular stroke and myocardial infarction
CA2379821A1 (en) Mixture for the treatment of waste materials
EP1161945A3 (de) Pharmazeutische Zusammensetzung enthaltend Prolin, Glycin und Lysin zur Behandlung von Sehnenverletzungen und offenen Wunden
BR9714179A (pt) Composição absorvìvel contendo bactérias propiÈnicas capazes de liberar monóxido de nitrogênio no tubo digestivo humano ou animal
DK0605381T3 (da) Polymerforbindelse, især til medicinske anvendelser
CA2281133A1 (en) Multiple-agents-binding compound and use thereof
AU2253197A (en) Novel substituted N-Methyl-N-(4-(4-(1H-benzimidazol- 2-yl){1,4}diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
EP0855191A3 (de) Methoden zur Behandlung von Oberflächenwunden mit Cyanoacrylatester-Zusammensetzungen, die antimikrobielle Verbindungen enthalten
EP0373388A3 (de) Penemderivate und Verfahren zu ihrer Herstellung
EP0337643A3 (de) 6-Substituierte Acrylamido-Penizillansäure-Derivate, Herstellung und Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee